FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C 702 MODULE

MDR report key: 7225183 · Received January 29, 2018

Report

Report Number
1823260-2018-00259
Event Type
Malfunction
Date Received
January 29, 2018
Date of Event
January 15, 2018
Report Date
February 9, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Additional Manufacturer Narrative · 1

DURING A REVIEW OF THE ALARM TRACE, THERE WERE MANY ABNORMAL SAMPLE ALARMS. THE INVESTIGATION DETERMINED THAT THE ERRONEOUS RESULTS WERE RELATED TO SAMPLE QUALITY DUE TO PRE-ANALYTIC ISSUES AT THE CUSTOMER SITE.

Description of Event or Problem · 1

THE CUSTOMER COMPLAINED OF ERRONEOUS LOW RESULTS FOR 3 PATIENT SAMPLES TESTED FOR HDLC3 HDL-CHOLESTEROL PLUS 3RD GENERATION (HDLC3) ON A COBAS 8000 C 702 MODULE. THE ERRONEOUS RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. PATIENT 1 INITIAL HDLC3 RESULT WAS 5.7 MG/DL. THE REPEAT RESULT WAS 38.3 MG/DL. PATIENT 2 INITIAL HDLC3 RESULT WAS 17.6 MG/DL. THE REPEAT RESULT WAS 72.2 MG/DL. PATIENT 3 INITIAL HDLC3 RESULT WAS 2.5 MG/DL. THE REPEAT RESULT WAS 39.3 MG/DL. THERE WAS NO ALLEGATION THAT AN ADVERSE EVENT OCCURRED. THE HDLC3 REAGENT LOT NUMBER WAS 242363 WITH AN EXPIRATION DATE OF 31-MAR-2019. THE FIELD SERVICE ENGINEER (FSE) VISITED THE CUSTOMER SITE AND CHANGED THE SAMPLE AND REAGENT PROBES, THE SAMPLE BOARD AND CLEANED THE FLUID LINE WITH BLEACH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
68383 COBAS 8000 C 702 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS C702 NA

Patients

Seq Age Sex Outcome Treatment
1